Recent advances in oncolytic virus therapy for hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is a highly refractory cancer and the fourth leading cause of cancer-related mortality worldwide. Despite the development of a detailed treatment strategy for HCC, the survival rate remains unsatisfactory. Oncolytic virus has been extensively researched as a new cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Licheng, Lei, Yu, Huang, Jia, An, Yahang, Ren, Yanqiao, Chen, Lei, Zhao, Huangxuan, Zheng, Chuansheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169724/
https://www.ncbi.nlm.nih.gov/pubmed/37182136
http://dx.doi.org/10.3389/fonc.2023.1172292

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169724/
https://www.ncbi.nlm.nih.gov/pubmed/37182136
http://dx.doi.org/10.3389/fonc.2023.1172292

Ejemplares similares